Associated Papers
Systematic Review of Genetic Factors in the Etiology of Esophageal Squamous Cell Carcinoma in African Populations.
Simba H et al.
Frontiers in Genetics, 2019
Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors.
Ferraresso M et al.
Clinical and Experimental Hypertension (new York, N.y. : 1993), 2011
Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.
Veiga MI et al.
European Journal of Clinical Pharmacology, 2009
Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa.
Ferreira PE et al.
Therapeutic Drug Monitoring, 2008
Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam.
Kharasch ED et al.
Clinical Pharmacology and Therapeutics, 2007
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir.
Josephson F et al.
Clinical Pharmacology and Therapeutics, 2007
Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Deeken JF et al.
Anti-cancer Drugs, 2007
Ethnic differences in the distribution of CYP3A5 gene polymorphisms.
Quaranta S et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 2006
Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition.
Lee SJ et al.
Journal of Clinical Pharmacology, 2006
Significance of the minor cytochrome P450 3A isoforms.
Daly AK
Clinical Pharmacokinetics, 2006
Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM et al.
Clinical Pharmacokinetics, 2006
CYP3A5 genotypes and risk of oesophageal cancer in two South African populations.
Dandara C et al.
Cancer Letters, 2005
Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivo.
He P et al.
Clinical Pharmacology and Therapeutics, 2005
An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore.
Chowbay B et al.
Drug Metabolism Reviews, 2005